Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

The ethical challenges of diversifying genomic data: A qualitative evidence synthesis

Hardcastle F. et al, (2023), Cambridge Prisms: Precision Medicine, 1 - 39

Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer.

Desai NV. et al, (2023), JCO precision oncology, 7

Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance.

Horton RH. et al, (2023), Journal of medical ethics

Ethical preparedness and developments in genomic healthcare.

Farsides B. and Lucassen AM., (2023), Journal of medical ethics

Facilitating genetic testing after death: the ongoing duty of care to the deceased and their relatives.

Dennis C. et al, (2023), Journal of the Royal Society of Medicine, 116, 193 - 198

Interventions to support patients with sharing genetic test results with at-risk relatives: a synthesis without meta-analysis (SWiM).

Ballard LM. et al, (2023), European journal of human genetics : EJHG

Utility of polygenic risk scores in UK cancer screening: a modelling analysis.

Huntley C. et al, (2023), The Lancet. Oncology

Immortal data: a qualitative exploration of patients' understandings of genomic data.

Lyle K. et al, (2023), Eur J Hum Genet

Realistic expectations are key to realising the benefits of polygenic scores

Sud A. et al, (2023), BMJ (Clinical research ed.), 380

Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparison

Horn R. et al, (2022), European Journal of Human Genetics

Ethical preparedness in health research and care: the role of behavioural approaches.

Samuel G. et al, (2022), BMC medical ethics, 23

Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis.

Horton RH. et al, (2022), British journal of cancer

Ethical issues raised by new genomic technologies: the case study of newborn genome screening

Horton R. and Lucassen A., (2022), Cambridge Prisms: Precision Medicine, 1 - 16

Exploring how biobanks communicate the possibility of commercial access and its associated benefits and risks in participant documents

Samuel G. et al, (2022), BMC Medical Ethics, 23

Access to Biobanks: Responsibilities Within a Research Ecosystem.

Samuel G. and Lucassen A., (2022), Biopreservation and biobanking

A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot.

Torr B. et al, (2022), Journal of medical genetics

Beyond regulatory approaches to ethics: making space for ethical preparedness in healthcare research.

Lyle K. et al, (2022), Journal of medical ethics

Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK).

Loong L. et al, (2022), Genetics in medicine : official journal of the American College of Medical Genetics

Ethical Considerations in Research with Genomic Data.

Horton R. and Lucassen A., (2022), The New bioethics : a multidisciplinary journal of biotechnology and the body, 1 - 15

Environmental sustainability and biobanking: a pilot study of the field

Samuel G. et al, (2022), New Genetics and Society, 41, 157 - 175

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?